LEADCARE ULTRA Trademark

Trademark Overview

On Thursday, November 21, 2013, a trademark application was filed for LEADCARE ULTRA with the United States Patent and Trademark Office. The USPTO has given the LEADCARE ULTRA trademark a serial number of 86125939. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, May 4, 2024. This trademark is owned by Magellan Diagnostics, Inc.. The LEADCARE ULTRA trademark is filed in the Medical Instrument Products category with the following description:

Medical devices to detect and measure the amount of lead in human blood
leadcare ultra

General Information

Serial Number86125939
Word MarkLEADCARE ULTRA
Filing DateThursday, November 21, 2013
Status800 - REGISTERED AND RENEWED
Status DateSaturday, May 4, 2024
Registration Number4567570
Registration DateTuesday, July 15, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2014

Trademark Statements

Pseudo MarkLEAD CARE ULTRA
NOT AVAILABLE"ULTRA"
Goods and ServicesMedical devices to detect and measure the amount of lead in human blood

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, December 6, 2013
Primary Code010
First Use Anywhere DateMonday, November 25, 2013
First Use In Commerce DateMonday, November 25, 2013

Trademark Owner History

Party NameMagellan Diagnostics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Billerica, MA 01862
Party NameMagellan Diagnostics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Billerica, MA 01862
Party NameMagellan Diagnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Billerica, MA 01862

Trademark Events

Event DateEvent Description
Saturday, December 7, 2013NOTICE OF PSEUDO MARK E-MAILED
Monday, November 25, 2013NEW APPLICATION ENTERED
Friday, December 6, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 17, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 6, 2014TEAS AMENDMENT OF USE RECEIVED
Friday, February 7, 2014USE AMENDMENT FILED
Friday, February 7, 2014AMENDMENT TO USE PROCESSING COMPLETE
Thursday, February 13, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 13, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 7, 2014ASSIGNED TO EXAMINER
Monday, March 17, 2014USE AMENDMENT ACCEPTED
Monday, March 17, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, March 17, 2014EXAMINERS AMENDMENT E-MAILED
Monday, November 19, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 17, 2014ASSIGNED TO LIE
Tuesday, March 18, 2014NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, March 18, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, March 19, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 21, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 29, 2014PUBLISHED FOR OPPOSITION
Tuesday, April 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 15, 2014REGISTERED-PRINCIPAL REGISTER
Monday, November 19, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 15, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 7, 2020TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 15, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 18, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, September 18, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, January 12, 2024TEAS SECTION 8 & 9 RECEIVED
Saturday, May 4, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, May 4, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, May 4, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, May 4, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, July 15, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

ultra leadcare lead human blood amount measure devices detect medical